[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
All Issues
Current Issue
Browse by Authors
Browse by Keywords
For Authors::
Call for Papers
Submission Instruction
Submission Form
For Reviewers::
Reviewers Section
Registration::
Registration Information
Registration Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 3, Issue 3 (12-2025) ::
Health Res Develop 2025, 3(3): 41-50 Back to browse issues page
Analysis of Demographic and Clinical Features of Patients Diagnosed With Parkinson's Disease at Alavi hospital in 2023: A Cross-Sectional Study
Ghasem Fattahzadeh Ardalani , Rezvan Parkalian *1 , Hamed Zandian , Negin Rahimi Ilkhchi
1- & Department of Neurology, School of Medicine, Ardabil university of Medical Sciecnes, Ardabil,Iran. , parkalianrezvan@gmail.com
Abstract:   (142 Views)
Background: Parkinson's disease is chronic and progressive, currently incurable, and is expected to impose a high economic and social burden on aging societies. Demographic characteristics play an important role in diagnosis, treatment, prognosis prediction, treatment planning and macro health policies.
Aim: This study aimed to analyze of demographic and clinical features of patients diagnosed with Parkinson's disease of Alavi Hospital during 2023
methods: In this cross-sectional and analytical study, 94 patients with Parkinson's disease referred to Alavi Hospital in Ardabil during 2023 were included. Demographic data, medical/family history, and treatment process were collected via medical records and interviews (using a checklist). The data were analyzed using SPSS version 27 at a significance level of p < 0.05.
Results: The mean age was 66.04 ± 11.8 years (62.8% male). Most were married (94.7%), urban residents (91.5%), and retired (58.5%). 11.7% had a family history of Parkinson's. Gender showed no significant association with symptom severity (P=0.621), but younger age at diagnosis correlated with higher severity (P=0.003). Positive family history was associated with greater severity (P=0.012).
Conclusion: The results of the present study indicated that although gender was not associated with the severity of Parkinson’s disease symptoms, younger age at diagnosis and a positive family history were linked to more severe manifestations. This highlights the significance of genetic factors and early disease onset in the clinical progression of Parkinson’s disease..
Keywords: Parkinson's disease, Demographic, Clinical
Keywords: Parkinson's disease, Demographic, Clinical
Full-Text [PDF 1231 kb]   (30 Downloads)    
Type of Study: Original | Subject: General
Received: 2025/07/24 | Accepted: 2025/09/2 | Published: 2025/09/7
References
1. James Parkinson, Member of the Royal College of Surgeons. An Essay on the Shaking Palsy. J of Neuropsychiatr Clin Neurosci. 2002;14(2):223-36. [DOI:10.1176/jnp.14.2.223] [PMID]
2. Kempster PA, Hurwitz B, Lees AJ. A new look at James Parkinson's Essay on the Shaking Palsy. Neurology. 2007;69(5):482-5. [DOI:10.1212/01.wnl.0000266639.50620.d1] [PMID]
3. Tysnes O-B, Storstein A. Epidemiology of Parkinson's disease. J Neur Trans. 2017;124(8):901-5. [DOI:10.1007/s00702-017-1686-y] [PMID]
4. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr. 2000;69(3):308-12. [DOI:10.1136/jnnp.69.3.308] [PMID] []
5. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr. 2008;79(4):368-76. [DOI:10.1136/jnnp.2007.131045] [PMID]
6. Alves G, Forsaa EB, Pedersen KF, Gjerstad MD, Larsen JP. Epidemiology of Parkinson's disease. J Neurol. 2008;255(5):18-32. [DOI:10.1007/s00415-008-5004-3] [PMID]
7. Hussain G, Rasul A, Anwar H, Sohail MU, Kamran SKS, Baig SM, et al. Epidemiological data of neurological disorders in Pakistan and neighboring countries: a review. Pakistan J Neurolog Sci. 2017;12(4):52-70.
8. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Eng J Med. 2003;348(14):1356-64. [DOI:10.1056/NEJM2003ra020003] [PMID]
9. Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson's Disease in a Japanese City. Arch Neurol. 1983;40(3):151-4. [DOI:10.1001/archneur.1983.04050030045008] [PMID]
10. Kurland L. Epidemiology: incidence, geographic distribution and genetic considerations. Pathogen Treat Parkinson. 1958:5-43.
11. De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-35. [DOI:10.1016/S1474-4422(06)70471-9] [PMID]
12. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson's disease: A systematic review and meta-analysis. Movement Disorders. 2014;29(13):1583-90. [DOI:10.1002/mds.25945] [PMID]
13. Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson's disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292-300. [DOI:10.1159/000445751] [PMID]
14. Roohani M, Ali Shahidi G, Miri S. Demographic study of parkinson's disease in Iran: Data on 1656 cases. Iran J Neurol. 2011;10(1-2):19-21.
15. Argüelles JL, Borroto Bermudez L, Sosa Aguila L, Rodriguez Carbajal A. Prevalence of Parkinson's disease in an urban area of Cienfuegos city. Int J Fam Commun Med. 2019;3(1):12-4. [DOI:10.15406/ijfcm.2019.03.00121]
16. Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Estimation of Parkinson's Disease Prevalence and Its Geographical Variation in Iran. J Mazandaran Univ Med Sci. 2021;31(200):113-24.
17. Salari M, Mirmosayyeb O, Etemadifar M, Shaygannejad V, Khorvash F, Najafi MR, et al. Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, Iran. Iran J Neurol. 2018;17(1):6-10.
18. Durmus H, Gokalp MA, Hanagasi HA. Prevalence of Parkinson's disease in Baskale, Turkey: a population based study. Neurolog Sci. 2015;36:411-3. [DOI:10.1007/s10072-014-1988-x] [PMID]
19. El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Hakeem NMA, Hamed MAA, et al. Prevalence of Parkinson's disease and other types of Parkinsonism in Al Kharga district, Egypt. Neuropsychiatr Dis Treat. 2013;12:1821-6. [DOI:10.2147/NDT.S48318] [PMID] []
20. Thiel M.F, Jost W.H. Sex and Gender Differences in Parkinson's Disease and the Conclusions we should Draw. J Neurol Disord 2024; 12:585.
21. Maclagan LC, Marras C, Sewell IJ, Wu CF, Butt DA, Tu K, et al. Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study. PLoS One. 2023;18(5):12-20. [DOI:10.1371/journal.pone.0285585] [PMID] []
22. Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, Wu CY, et al. Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiol. 2009;33(4):350-7. [DOI:10.1159/000254572] [PMID]
23. Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M, et al. Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study. Lancet Region Health Am. 2022;7:12-20. [DOI:10.1016/j.lana.2021.100136] [PMID] []
24. Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, et al. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol. 2010;172(12):1357-63. [DOI:10.1093/aje/kwq303] [PMID] []
25. Tarsy D. Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. Jama. 2012;307(21):2305-14. [DOI:10.1001/jama.2012.4829] [PMID]
26. Malek N, Bajaj N, Barker R, Ben-Shlomo Y, Burn D, Foltynie T, et al. FAMILY HISTORY IN YOUNG ONSET PARKINSON'S DISEASE. J Neurol Neurosurg Psychiat. 2013;84(11):2-12. [DOI:10.1136/jnnp-2013-306573.160]
27. Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology. 1999;18(5):270-8. [DOI:10.1159/000026222] [PMID]
28. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 2001;1:12-20.
29. Golbe LI, Leyton CE. Life expectancy in Parkinson disease. J Psychiatr Res. 2018;91(22):991-2. [DOI:10.1212/WNL.0000000000006560] [PMID]
30. Aggarwal S, Paul G, Paul BS, Mahendru D, Goyal S. Factors Affecting Adherence to Pharmacotherapy in Parkinson's Disease. Ann Indian Acad Neurol. 2021;24(6):879-84.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.ARUMS.MEDICINE.REC.1401.023
Clinical trials code: 0

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fattahzadeh Ardalani G, Parkalian R, Zandian H, Rahimi Ilkhchi N. (2025). Analysis of Demographic and Clinical Features of Patients Diagnosed With Parkinson's Disease at Alavi hospital in 2023: A Cross-Sectional Study. Health Res Develop. 3(3), 41-50.
URL: http://jhrd.trjums.ac.ir/article-1-123-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3, Issue 3 (12-2025) Back to browse issues page
پژوهش و توسعه سلامت Health research and development
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4718